Summary
Pharmaceutical firms are changing their business operating models in response to market globalization, consolidation, and regulatory pressures. These changes require a stronger partnership between business and IT. Business capability maps provide a framework for capturing key characteristics of a firm's business model and core functions — characteristics that you then can use to assess business needs, understand IT costs, and align investments with strategic priorities. This report explains how pharmaceutical firms can use capability maps to illustrate changes in the operating model and to support the business-IT partnership.
Log in to continue reading
Client log in
Welcome back. Log in to your account to continue reading this research.
Become a client
Become a client today for these benefits:
- Stay ahead of changing market and customer dynamics with the latest insights.
- Partner with expert analysts to make progress on your top initiatives.
- Get answers from trusted research using Izola, Forrester's genAI tool.
Purchase this report
This report is available for individual purchase ($1495).